Mutants of Arabidopsis thaliana with a glucosinolate content different from wild type were isolated by screening a mutagenized population of plants. Six mutants were detected out of a population of 1200 screened. One of these mutants, TUI, was analyzed in detail. Leaf and seed tissues of line TUl lack or have reduced amounts of many of the aliphatic glucosinolates found in the wild type due to a recessive allele, gsml, of a single nuclear gene, GSM1. The seed phenotype is inherited as a maternal effect suggesting that the embryo is dependent on the maternal tissue for its glucosinolates. Experiments involving feeding of "4C-labeled intermediates suggested that the gsml allele results in a metabolic block which decreases the availability of several amino acid substrates required for glucosinolate biosynthesis: 2-amino-6-methylthiohexanoic acid, 2-amino-7-methylthioheptanoic acid, and 2-amino-8-methylthiooctanoic acid. The mutation does not result in any obvious changes in morphology or growth rate. A pathway for the biosynthesis of glucosinolates in A. thaliana is proposed.
condiment crops (e.g. mustard, cabbage) is due, primarily, to isothiocyanates derived from the catabolism ofglucosinolates. Finally, the isothiocyanates derived from the catabolism of many glucosinolates, are toxic to some bacterial and fungal pathogens. The same isothiocyanates discourage feeding by some insect species but act as attractants or behavior modifying chemicals for others. The possibility of improving the commercial value of some crops by manipulating the levels of glucosinolates in certain tissues has generated interest in understanding the biochemistry and genetics of glucosinolate biosynthesis.
Much of our knowledge concerning the biosynthesis of glucosinolates is derived from in vivo labeled precursor studies. These studies led to the proposal ofa general glucosinolate biosynthetic pathway (17, 26) . In essence, amino acids are considered to be the precursors of all glucosinolates. Both protein and nonprotein amino acids serve as substrates for a biochemical pathway of at least five steps: amino acid (1)--N-hydroxyamino acid (2)-* aldoxime (3)-* thiohydroximate (4)-* desulfoglucosinolate (5)--glucosinolate. Enzymatic activities capable of catalyzing steps (1) , (2) , (4) , and (5) have been reported (8, 12, 14, 20, 21) .
In contrast to our knowledge of glucosinolate chemistry and biochemistry, very little is known about the genes which encode the biosynthetic enzymes (6) . To this end, we have initiated a program in biochemical genetics of glucosinolate metabolism in Arabidopsis thaliana with the purposes of better defining the glucosinolate biosynthetic pathway, establishing the relationship between leaf and seed glucosinolate biosynthesis, determining which genes, if any, are common to the biosynthesis of all glucosinolates, and evaluating the physiological effects of blocking specific biosynthetic steps. Such information is a prerequisite to our long-term goal of using molecular genetics to manipulate glucosinolate levels in crop species.
We have recently characterized seed and leaf glucosinolates of A. thaliana (1 1) . The chemistry of the 23 different glucosinolates that have been identified (Table I ) and the biochemical analyses done in other glucosinolate bearing species, make it possible to predict that all are derived from just three protein amino acids. Three glucosinolates (Table I; glucosinolates 16, 17, 18) contain a 3-indolylmethyl nucleus that could originate from tryptophan (13, 16, 19) . The 2-phenylethyl glucosinolate Hypothetical pathway for the biosynthesis of glucosinolates from methionine in tissues of A. thaliana. Compounds shown in the biosynthetic pathway for the aliphatic glucosinolates (keto acids, amino acids, and glucosinolates) vary with respect to side groups on (R, horizontal axis) and the overall length (n, vertical axis) of their carbon side-chain. The arrows denote one or more enzymatically catalyzed reactions: a, transamination; b, carbon-chain elongation pathway; c, conversion of an amino acid to a methylthioglucosinolate and subsequent modification of the carbon side-chain. The direction of the arrow indicates the normal direction of carbon flow. The glucosinolate numbers refer to those given in Table I . 2-A-8-MTO, 2-amino-8-methylthiooctanoic acid; 2-A-9-MTN; 2-amino-9-methylthiononanoic acid; 2-A-1 0-MTD, 2-amino-1 0-methylthiodecanoic acid; 2-K-4-MTB, 2-keto-4-methylthiobutanoic acid; 2-K-5-MTP, 2-keto-5-methylthiopentanoic acid; 2-K-6-MTH, 2-keto-6-methylthiohexanoic acid; 2-K-7-MTH, 2-keto-7-methylthioheptanoic acid; 2-K-8-MTO, 2-keto-8-methylthiooctanoic acid; 2-K-9-MTN, 2-keto-9-methylthiononanoic acid; 2-K-10-MTD, 2-keto-10-methylthiodecanoic acid. The putative position of the gsml metabolic block (a3, a4, a5) is indicated by //.
found in only trace amounts in A. thaliana may be derived from phenylalanine (25; Table I, 23) . Methionine is probably the precursor for the remaining 19 glucosinolates (see Fig. 1 ). The w-methylthio glucosinolates (Table I ; glucosinolates 1-6) may be derived from methionine by way of a chain-extension pathway (26) to produce a homologous series of amino acids (R = CH3S(CH2)n; n = 3-8) which, in turn, serve as precursors for glucosinolate biosynthesis. Additional modification of aliphatic side chains could generate the corresponding series of w-methylsulfinyl glucosinolates (Table I, [7] [8] [9] [10] [11] [12] , the benzoyloxy glucosinolates (Table I, (1 ,umol) in the tip of a 1.5 mL microfuge (feeding) tube. Following uptake ofthe solution (approximately 1 h), three 50 ,L aliquots ofwater were added and allowed to be absorbed in succession (each wash was approximately 1 h). Uptake of the compounds was calculated by determining the remaining radioactivity in the tube. The shoots were then transferred to a 1.5 mL microfuge tube containing 1 mL of water enclosed inside a tray with transparent lid (to prevent desiccation) and incubated for 20 to 22 h in a growth chamber (22°C, 100 juE/m2/s continuous light).
Each compound was fed separately to six plants. The six plants were bulked, the glucosinolates extracted, converted to desulphoglucosinolates, and separated by HPLC. The effluent from the column was analyzed by UV spectroscopy and assayed for radioactivity by mixing with scintillant (Flo-Scint III, Radiomatic Instruments and Chemical Co., Tampa, FL) at a rate of 1.5 mL/min to give a total flow rate of 2 mL/min upon entering the Flo-One detector.
RESULTS

Mutant Isolation
Leaf tissue of A. thaliana contains a characteristic array of glucosinolates which can be detected by converting to their desulfo analogs and separating by liquid chromatography (1 1) . We sought to isolate mutants defective in glucosinolate metabolism by screening, individually, large numbers of ethyl methane sulfonate mutagenized plants (M2 generation) for those with a glucosinolate profile that differed significantly from that of the wild type. To facilitate the screening, we modified the extraction procedure previously reported (11) such that the glucosinolate content of leaves of individual plants could be more rapidly determined without sacrificing the plants. The oldest four leaves of a plant were harvested (sample sizes were between 6 and 500 mg) and the glucosinolates extracted in boiling water without tissue homogenization. The HPLC chromatograms ofglucosinolates extracted in this way ( Fig. 2A) were similar to those of glucosinolates extracted from bulk tissue (cf. Fig. 2A with Fig. 3A Figure 2 . A fifth (TU5) and a sixth (TU6) line were phenotypically similar to line TU1 (Fig. 2B ) and line TU3 (Fig. 2C) Table I . Identification was based on elution time relative to the standard (STD) o-nitrophenyl-f-D-galactopyranoside and analysis by mass spectrometry.
by HPLC as described in "Materials and Methods" ( Fig. 3 ; Table II ). The identities of the desulphoglucosinolates were verified using LC-MS (data not shown). Of the 19 glucosinolates that could be detected by our HPLC analysis, line TU 1 had greatly reduced amounts of the eight aliphatic glucosinolates that had a side-chain carbon length (n) of 4, 5, and 6 (glucosinolates 2, 3, 4, 8, 9, 10, 14, and 20; Table II ). In addition, the mutant contained higher than wild-type levels of aliphatic glucosinolates where n = 3 (7, 13, and 19; see Table II ). These results suggest that TU1 has a metabolic block in the biosynthetic pathway for aliphatic glucosinolates (Fig. 1 ).
Genetic Analysis of Line TUl
To determine the mode of inheritance of the TU 1 glucosinolate phenotype, reciprocal crosses were made between line TU1 and line MSU8 (gil). The F, and F2 progeny were scored for TU I or wild-type glucosinolate content (gsm and GSM, respectively) in leaf tissue and, as a control the recessive nuclear marker gll (lack of leaf trichomes). The F, progeny from both crosses had a wild-type phenotype while the F2 progeny were approximately 9 GSM, GLI/_: 3 GSM, glll gll: 3 gsm, GLI/_: I gsm, gil/gll (Table III) . These data suggest that the TU 1 leaf glucosinolate phenotype is due to a recessive allele of a single nuclear gene (designated gsml-l for glucosinolate metabolism) which segregates independently of the GLI gene.
Three lines of evidence support the hypothesis that the novel seed glucosinolate content of line TU1 is also due to the gsml-l allele and not to an independent mutation. First, gsml-l\gsml-l F2 plants from each of the crosses TU1 x MSU8 and MSU8 x TU 1 produced seed with a glucosinolate content identical to that of line TU 1. Second, the TU1 seed and leaf glucosinolate phenotypes cosegregated through six backcrosses to wild type. Third, line TU5 is homozygous for an independently derived recessive allele of the GSM1 gene. The glucosinolate content of both leaf and seed tissues of line TU5 are similar to line TU 1 (data not shown).
The glucosinolate content of Fl seed (batches of 100) from the crosses oflines TU 1 and MSU8 were also examined (Table  III) . As expected, Fl seed from the cross MSU8 x TUl had a wild-type seed glucosinolate content. In contrast, Fl seed from the reciprocal cross (TU1 x MSU8) had a TU 1-like glucosinolate content suggesting that the seed glucosinolate phenotype is under maternal control.
In Vivo Labeling of Glucosinolates With 14C Intermediates
The nature of the phenotype of line TU 1 suggests that the GSMI gene encodes an enzyme common to the biosynthesis of several of the aliphatic glucosinolates. We attempted to determine more about the biosynthetic pathway and the position of this metabolic block by feeding five different 2-C'4-labeled, putative-precursors of aliphatic glucosinolates to wild type and TU1 (gsml-l/gsml-l) shoots: acetate and amino acids, methionine (Fig. 1, n = 2 ), 2-A-5-MTP (Fig. 1 , n = 3), 2-A-6-MTH (Fig. 1, n = 4) , and 2-A-7-MTH (Fig. 1 , n = 5). The glucosinolates from the fed shoots were separated by HPLC and analyzed by UV absorption and flow through scintillation counter. Uptake of the fed compounds by the shoots was between 45.4 and 79.1%, while the recovery in the glucosinolate fraction was: acetate: 1.5% (wild type), 0.5% (TUI); methionine: 3.2% (wild type), 1.6% (TUl); 2-A-5-MTP: 4.6% (wild type), 9.0% (TU 1); 2-A-6-MTH: 4.2% (wild type), 6.5% (TU1); 2-A-7-MTH: 5.0% (wild type), 11 .0% (TU1). As expected, only the aliphatic glucosinolates were radiolabeled. Radioactivity was never found in the indole glucosinolate fractions.
The radioactivity incorporated into individual aliphatic glucosinolates in shoots of wild type and line TU 1 are shown in Figures 4 and 5 with the proposed pathway for glucosinolate biosynthesis in Brassicaceae (26; Fig. 1 ) as follows. First, when methionine, acetate, and 2-A-5-MTP were fed, all detectable aliphatic glucosinolates produced by the shoots were radiolabeled (glucosinolates 2, 7, 8, 9, 10, 11, and 12 in wild type, Fig. 4 , A-C; data not shown for line TU1) suggesting that all three compounds are precursors of all of the aliphatic glucosinolates. Second, the proportion of radioactivity incorporated into glucosinolates of carbon side-chain length n was highest when shoots were fed an amino acid with a carbon side-chain length n. For example, when wild-type shoots were fed 2-A-7-MTH (n = 5), a higher proportion of the radioactivity recovered in the glucosinolate fraction was associated with glucosinolates 3 and 9 (n = 5; Fig. 4E ) than when any other compound was fed. Indeed, glucosinolate 3 which is not normally detectable in leaf tissue (Table II) was synthesized when shoots were fed 2-A-7-MTH (Fig. 4E, Fig. SC) . These data suggest that amino acids of carbon length n are limiting substrates for biosynthesis of all glucosinolates of carbon length n. Third, shoots fed amino acids of carbon chain length n were found to have radiolabeled aliphatic glucosinolates of carbon chain length greater than, but not less than, n. For example, wild-type shoots fed 2-A-6-MTH (n = 5) contained radiolabeled glucosinolates 9 (n = 5) and 12 (n = 8) but not 7 (n = 3) (Fig. 4D) , despite the fact that glucosinolate 7 was the second most abundant glucosinolate in the shoots (data not shown). Similarly, when TU1 shoots were fed 2-A-7-MTH no label was observed in 3-methylsulphinylpropyl glucosinolate (Fig. 5C) although it was the second most abundant aliphatic glucosinolate produced in the leaves. These data are Table I expected if, as proposed ( Fig. 1) , the aliphatic glucosinolates are biosynthesized from methionine by successive additions of acetate-derived carbon atoms. Shoots of line TU1 synthesize less than wild-type levels of glucosinolates 2, 8, and 9 (Fig. 3B) . Figure 6 shows the HPLC chromatograms ofglucosinolates (absorption at 226 nm) from shoots of TU1 plants fed 1 umol of the five compounds indicated. Shoots that were fed three of the compounds (acetate, methionine, 2-A-5-MTP; Fig. 6 , A-C, respectively) were not different in glucosinolate content from shoots fed only water (data not shown; Cj. Fig. 6, A-C to Fig. 3B ). By contrast, the feeding of 2-A-6-MTH and 2-A-7-MTH resulted in an increase of the synthesis of glucosinolates 2, 8, and 9, respectively (e.g. in Fig. 6 , ctf the level of incorporation in the glucosinolate 8 fraction between plants fed 2-A-5-MTP, Fig.  6C versus 2-A-6-MTH, Fig. 6D) suggesting that in the mutant these amino acids are limiting substrates and lie downstream of the TU1 metabolic block. Using the same reasoning one can conclude that methionine and 2-A-5-MTP are not limiting and, therefore, lie upstream of the metabolic block. The observed increase in the steady-state levels of n = 3 glucosinolates in the TU 1 mutant is consistent with this conclusion.
Growth Analysis
Blocks in biosynthetic pathways can result in detrimental effects on plant growth because of the build-up of toxic intermediates or the loss of end products. The effect of the gsml-l allele on shoot growth was tested as follows. Flats were planted with alternating rows of wild-type and TU1 plants and kept at 4°C for 7 . Glucosinolates in TUl shoots after feeding various compounds. The analysis was done as described in Figure 4 . Specific desulfoglucosinolates are identified by numbers which correspond to those used in Table I 
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Deamination of methionine (Fig. 1, step a] ) and multiple rounds of carbon chain-extension using acetate as a donor (Fig. 1 , step bl-b6) produces a homologous series of ketoacids which vary only in the length of the carbon side chain. The ketoacids are then transaminated and the glucosinolate moiety synthesized to produce a homologous series of methylthio glucosinolates (Fig. 1, steps cl-c6) . The methylthio glucosinolates, in turn, can be substrates for several enzymes which modify the methylthio side chain to produce the -methyl sulfinyl, -hydroxy, and benzoyloxy glucosinolates (Fig. 1, steps cl-c6 ). quency of mutations obtainable in ethyl methane sulfonate mutagenized populations of A. thaliana (10) eliminates the need to screen more than a few thousand plants to have a high probability of isolating a given mutant. It should be possible to use an HPLC screen to isolate mutants of A. thaliana with lesions in the biochemical pathways of many nonessential secondary metabolites.
We have analyzed one ofthese mutant lines (TU 1) in detail. Line TU 1 is unable to synthesize wild-type levels of many aliphatic glucosinolates because it is homozygous for a recessive mutant allele (gsml-l) of the nuclear gene GSMJ. It is likely, therefore, that the product of GSMI is required for an enzymatic step in the glucosinolate biosynthetic pathway and that the gsml-J allele results in partial loss of function.
Although experiments reported here have not identified the exact metabolic block in TU 1, only a few possibilities exist if we assume that, in general, the biosynthetic pathway proposed in Figure 1 is correct. We can deduce, from the feeding experiments, that the GSMJ product is not required for any biosynthetic step prior to 2-A-5-MTP nor for any step between amino acids 2-A-5-MTP, 2-A-6-MTH, and 2-A-7-MTH and their corresponding glucosinolates n = 3, 4, and 5 ( Fig. 1,  steps cl-c3) . The biosynthesis of glucosinolates 11 and 12 (n = 7, 8, respectively) appears to be relatively unaffected in line TU 1. Because the biosynthesis of glucosinolates 11 and 12 depend on the activity of all of the enzymes involved in chain extension (Fig. 1, steps bl-h6 ) the GSMI gene product could not be required for any chain-extension reactions. The TU1 metabolic block must, therefore, be involved in the biosynthesis of 2-A-6-MTH, 2-A-7-MTH, and 2-A-8-MTO from their respective ketoacids (steps a3-a5, Fig. 1 ).
The GSM 1 gene product could be: an intracellular transporter of ketoacids as would be needed if carbon-chain extension and transamination occur in different cellular compartments; a transaminase which recognizes as a substrate wmethylthio ketoacids of only specific carbon-chain lengths. The hypothesis could be tested by synthesizing and feeding the appropriate ketoacids to TU1 and wild-type lines. It should be noted that radioactivity was detected in the glucosinolate 12 fraction after feeding TU 1 plants 2-A-6-MTH and 2-A-7-MTH indicating that TU 1 plants have the capability of deaminating those amino acids; or a protein needed for release of the ketoacid from a carbon-chain extension enzyme complex. Such a hypothesis assumes that all the observed carbonchain extension is catalyzed by a single enzyme complex which uses the ketoacid it synthesizes as a substrate for a subsequent series of reactions (analogous to channeling in the biosynthesis of cyanogenic glucosides, 21; or the fatty-acid synthetase complex, 23).
Levels of both n = 3 and n = 8 glucosinolates in shoots of TU 1 are not decreased in plants homozygous for the gsml-l allele. These data suggest that the transamination occurring in steps a2, a6, and a7 must be catalyzed by the products of genes other than GSMJ. Lines TU3 and TU6, which have lower than wild-type levels of n = 8 glucosinolates 6 and 12, may be deficient for a transaminase required for step a7 (Fig. 1) .
The gsml-J allele affects the glucosinolate content of both leaf and seed tissues similarly. However, the seed phenotype, unlike that ofthe leaf, is inherited as a maternal effect. Control of seed glucosinolates by the maternal genotype has been reported previously (e.g. Brassica napus, 15, 18) . Such data indicate that biosynthesis of leaf glucosinolates is dependent on enzymes encoded by the zygotic genome, whereas the biosynthesis of seed glucosinolate is dependent on enzymes encoded by the maternal genome. The biosynthesis of seed glucosinolates could involve the transport of glucosinolate biosynthetic enzymes, the RNA encoding those enzymes, or glucosinolates themselves, from the maternal tissues to the embryo. Consistent with the latter hypothesis are recent physiological studies that have suggested that embryos of B. napus developing in vitro acquire their glucosinolates from the exogenous medium rather than synthesizing them de novo (5, 7) .
If seed glucosinolates are indeed derived from maternal tissue, two important predictions can be made which relate to the manipulation of glucosinolate content in plants. First At present, our screen for mutants has identified only a small number of the genes that one might predict would be involved in glucosinolate biosynthesis. This is not unusual considering the small number ofplants screened and estimates of mutation frequencies in our mutagenized stocks (10 
